Alzheimers Disease Diagnostics Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology 

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Alzheimer’s Disease Diagnostics Market 

5.1. COVID-19 Landscape: Alzheimer’s Disease Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Alzheimer’s Disease Diagnostics Market, By Diagnostic Type

8.1. Alzheimer’s Disease Diagnostics Market, by Diagnostic Type

8.1.1. Brain Imaging

8.1.1.1. Market Revenue and Forecast

8.1.2. Biomarker Testing

8.1.2.1. Market Revenue and Forecast

8.1.3. Genetic Testing

8.1.3.1. Market Revenue and Forecast

8.1.4. Cognitive Assessment Tests

8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Alzheimer’s Disease Diagnostics Market, By Technology

9.1. Alzheimer’s Disease Diagnostics Market, by Technology

9.1.1. Imaging Technologies

9.1.1.1. Market Revenue and Forecast

9.1.2. Molecular Diagnostics

9.1.2.1. Market Revenue and Forecast

9.1.3. Immunoassays

9.1.3.1. Market Revenue and Forecast

9.1.4. AI & Digital Diagnostics

9.1.4.1. Market Revenue and Forecast

Chapter 10. Global Alzheimer’s Disease Diagnostics Market, By End-use 

10.1. Alzheimer’s Disease Diagnostics Market, by End-use

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast

10.1.2. Diagnostic Laboratories

10.1.2.1. Market Revenue and Forecast

10.1.3. Specialty Neurology Clinics

10.1.3.1. Market Revenue and Forecast

10.1.4. Academic & Research Institutes

10.1.4.1. Market Revenue and Forecast

Chapter 11. Global Alzheimer’s Disease Diagnostics Market, By Application

11.1. Alzheimer’s Disease Diagnostics Market, by Application

11.1.1. Early-stage Diagnosis

11.1.1.1. Market Revenue and Forecast

11.1.2. Mild Cognitive Impairment Detection

11.1.2.1. Market Revenue and Forecast

11.1.3. Disease Monitoring

11.1.3.1. Market Revenue and Forecast

11.1.4. Clinical Research & Drug Development

11.1.4.1. Market Revenue and Forecast

Chapter 12. Global Alzheimer’s Disease Diagnostics Market, By Age Group

12.1. Alzheimer’s Disease Diagnostics Market, by Age Group

12.1.1. Below 65 Years

12.1.1.1. Market Revenue and Forecast

12.1.2. 65–80 Years

12.1.2.1. Market Revenue and Forecast

12.1.3. Above 80 Years

12.1.3.1. Market Revenue and Forecast

Chapter 13. Global Alzheimer’s Disease Diagnostics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Diagnostic Type

13.1.2. Market Revenue and Forecast, by Technology

13.1.3. Market Revenue and Forecast, by End-use

13.1.4. Market Revenue and Forecast, by Application

13.1.5. Market Revenue and Forecast, by Age Group

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Diagnostic Type

13.1.6.2. Market Revenue and Forecast, by Technology

13.1.6.3. Market Revenue and Forecast, by End-use

13.1.6.4. Market Revenue and Forecast, by Application

13.1.6.5. Market Revenue and Forecast, by Age Group  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Diagnostic Type

13.1.7.2. Market Revenue and Forecast, by Technology

13.1.7.3. Market Revenue and Forecast, by End-use

13.1.7.4. Market Revenue and Forecast, by Application

13.1.7.5. Market Revenue and Forecast, by Age Group

13.2. Europe

13.2.1. Market Revenue and Forecast, by Diagnostic Type

13.2.2. Market Revenue and Forecast, by Technology

13.2.3. Market Revenue and Forecast, by End-use

13.2.4. Market Revenue and Forecast, by Application  

13.2.5. Market Revenue and Forecast, by Age Group  

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Diagnostic Type

13.2.6.2. Market Revenue and Forecast, by Technology

13.2.6.3. Market Revenue and Forecast, by End-use

13.2.7. Market Revenue and Forecast, by Application  

13.2.8. Market Revenue and Forecast, by Age Group  

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Diagnostic Type

13.2.9.2. Market Revenue and Forecast, by Technology

13.2.9.3. Market Revenue and Forecast, by End-use

13.2.10. Market Revenue and Forecast, by Application

13.2.11. Market Revenue and Forecast, by Age Group

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Diagnostic Type

13.2.12.2. Market Revenue and Forecast, by Technology

13.2.12.3. Market Revenue and Forecast, by End-use

13.2.12.4. Market Revenue and Forecast, by Application

13.2.13. Market Revenue and Forecast, by Age Group

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Diagnostic Type

13.2.14.2. Market Revenue and Forecast, by Technology

13.2.14.3. Market Revenue and Forecast, by End-use

13.2.14.4. Market Revenue and Forecast, by Application

13.2.15. Market Revenue and Forecast, by Age Group

13.3. APAC

13.3.1. Market Revenue and Forecast, by Diagnostic Type

13.3.2. Market Revenue and Forecast, by Technology

13.3.3. Market Revenue and Forecast, by End-use

13.3.4. Market Revenue and Forecast, by Application

13.3.5. Market Revenue and Forecast, by Age Group

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Diagnostic Type

13.3.6.2. Market Revenue and Forecast, by Technology

13.3.6.3. Market Revenue and Forecast, by End-use

13.3.6.4. Market Revenue and Forecast, by Application

13.3.7. Market Revenue and Forecast, by Age Group

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Diagnostic Type

13.3.8.2. Market Revenue and Forecast, by Technology

13.3.8.3. Market Revenue and Forecast, by End-use

13.3.8.4. Market Revenue and Forecast, by Application

13.3.9. Market Revenue and Forecast, by Age Group

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Diagnostic Type

13.3.10.2. Market Revenue and Forecast, by Technology

13.3.10.3. Market Revenue and Forecast, by End-use

13.3.10.4. Market Revenue and Forecast, by Application

13.3.10.5. Market Revenue and Forecast, by Age Group

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Diagnostic Type

13.3.11.2. Market Revenue and Forecast, by Technology

13.3.11.3. Market Revenue and Forecast, by End-use

13.3.11.4. Market Revenue and Forecast, by Application

13.3.11.5. Market Revenue and Forecast, by Age Group

13.4. MEA

13.4.1. Market Revenue and Forecast, by Diagnostic Type

13.4.2. Market Revenue and Forecast, by Technology

13.4.3. Market Revenue and Forecast, by End-use

13.4.4. Market Revenue and Forecast, by Application

13.4.5. Market Revenue and Forecast, by Age Group

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Diagnostic Type

13.4.6.2. Market Revenue and Forecast, by Technology

13.4.6.3. Market Revenue and Forecast, by End-use

13.4.6.4. Market Revenue and Forecast, by Application

13.4.7. Market Revenue and Forecast, by Age Group

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Diagnostic Type

13.4.8.2. Market Revenue and Forecast, by Technology

13.4.8.3. Market Revenue and Forecast, by End-use

13.4.8.4. Market Revenue and Forecast, by Application

13.4.9. Market Revenue and Forecast, by Age Group

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Diagnostic Type

13.4.10.2. Market Revenue and Forecast, by Technology

13.4.10.3. Market Revenue and Forecast, by End-use

13.4.10.4. Market Revenue and Forecast, by Application

13.4.10.5. Market Revenue and Forecast, by Age Group

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Diagnostic Type

13.4.11.2. Market Revenue and Forecast, by Technology

13.4.11.3. Market Revenue and Forecast, by End-use

13.4.11.4. Market Revenue and Forecast, by Application

13.4.11.5. Market Revenue and Forecast, by Age Group

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Diagnostic Type

13.5.2. Market Revenue and Forecast, by Technology

13.5.3. Market Revenue and Forecast, by End-use

13.5.4. Market Revenue and Forecast, by Application

13.5.5. Market Revenue and Forecast, by Age Group

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Diagnostic Type

13.5.6.2. Market Revenue and Forecast, by Technology

13.5.6.3. Market Revenue and Forecast, by End-use

13.5.6.4. Market Revenue and Forecast, by Application

13.5.7. Market Revenue and Forecast, by Age Group

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Diagnostic Type

13.5.8.2. Market Revenue and Forecast, by Technology

13.5.8.3. Market Revenue and Forecast, by End-use

13.5.8.4. Market Revenue and Forecast, by Application

13.5.8.5. Market Revenue and Forecast, by Age Group

Chapter 14. Company Profiles

14.1. F. Hoffmann-La Roche Ltd.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Siemens Healthineers

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. GE HealthCare

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Fujirebio

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Quest Diagnostics

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Labcorp

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Canon Medical Systems

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Philips Healthcare

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Bio-Rad Laboratories

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Quanterix

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms